Epinephrine Autoinjector Market Report by Dosage (0.15mg Epinephrine Autoinjector, 0.3mg Epinephrine Autoinjector, 0.5mg Epinephrine Autoinjector), Application (Under 6 Years, 6 to 12 Years, Over 12 Years), End User (Hospitals, Clinics, and Others), and Region 2024-2032

Epinephrine Autoinjector Market Report by Dosage (0.15mg Epinephrine Autoinjector, 0.3mg Epinephrine Autoinjector, 0.5mg Epinephrine Autoinjector), Application (Under 6 Years, 6 to 12 Years, Over 12 Years), End User (Hospitals, Clinics, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A7369
Buy Now

Market Overview:

The global epinephrine autoinjector market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2032, exhibiting a growth rate (CAGR) of 8.21% during 2024-2032. The increasing number of individuals with allergies, rising need for self-administrating medicines, and the launch of smart epinephrine autoinjector represent some of the key factors driving the market.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 2.4 Billion
Market Forecast in 2032
US$ 5.0 Billion
Market Growth Rate 2024-2032 8.21%


Epinephrine autoinjector is a medical device used to administer single dose epinephrine easily for treating severe allergic reactions caused by stings, bug bites, or drugs. It is designed to deliver the medication into the thigh muscle of an individual and works by constricting blood vessels and dilating the airways to minimize the symptoms of an allergic reaction. It is small and easy to carry and can be administered by individuals or healthcare professionals. At present, leading manufacturers are introducing epinephrine autoinjector with multiple doses of medications and adjustable dosages that enable the user to adjust the dose according to the severity of the allergic reaction and improve the effectiveness of the treatment. They are also incorporating audio and visual instructions to make it easier for individuals to use them in an emergency. 

Epinephrine Autoinjector Market Trends:

The increasing number of individuals with allergies and allergic reactions and the rising need for self-administrating medicines represent one of the major factors driving the demand for epinephrine autoinjectors around the world. Moreover, the surging prevalence of arthritis, asthma, cancer, and chronic obstructive pulmonary disease (COPD) and the growing aging population, which is more prone to develop allergic reactions, is influencing the market positively. In addition, the increasing incidence of food allergies among the masses is bolstering the growth of the market. Apart from this, governing agencies of numerous countries are undertaking initiatives to promote the use of epinephrine autoinjectors in schools and other public spaces. This, coupled with the rising awareness about epinephrine autoinjectors, is contributing to the market growth. Furthermore, key players are introducing smart epinephrine autoinjectors that are integrated with advanced technologies, including Bluetooth connectivity, sensors, and machine learning, to make them more convenient, user friendly, and effective. Leading players are also launching mobile applications that can be connected to smartphones or other devices, allowing remote monitoring, tracking of usage and expiration dates, and ensuring the patient does not exceed the recommended dosage. These advancements can also help predict the likelihood of an allergic reaction and provide personalized recommendations for treatment. This, along with the incorporation of an automated external defibrillator (AED) in epinephrine autoinjectors to offer a comprehensive emergency response system, is creating a positive outlook for the market.  

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global epinephrine autoinjector market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on dosage, application, and end user.

Dosage Insights:

  • 0.15mg Epinephrine Autoinjector
  • 0.3mg Epinephrine Autoinjector
  • 0.5mg Epinephrine Autoinjector
     

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the dosage. This includes 0.15mg epinephrine autoinjector, 0.3mg epinephrine autoinjector, and 0.5mg epinephrine autoinjector. According to the report, 0.3mg epinephrine autoinjector represented the largest segment.

Application Insights:

  • Under 6 Years
  • 6 to 12 Years
  • Over 12 Years
     

A detailed breakup and analysis of the epinephrine autoinjector market based on the application has also been provided in the report. This includes under 6 years, 6 to 12 years, and over 12 years. According to the report, 6 to 12 years represented the largest segment.

End User Insights:

  • Hospitals
  • Clinics
  • Others
     

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the end user. This includes hospitals, clinics, and others. According to the report, hospitals represented the largest segment.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for epinephrine autoinjectors. Some of the factors driving the North America epinephrine autoinjector market included the rising prevalence of allergies, increasing awareness about anaphylaxis, and the availability of cost-effective generic versions of autoinjectors.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global epinephrine autoinjector market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Adamis Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Antares Pharma Inc, Bausch Health, Kaleo Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Dosages Covered 0.15mg Epinephrine Autoinjector, 0.3mg Epinephrine Autoinjector, 0.5mg Epinephrine Autoinjector
Applications Covered Under 6 Years, 6 to 12 Years, Over 12 Years
End Users Covered Hospitals, Clinics, Others
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Adamis Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Antares Pharma Inc, Bausch Health, Kaleo Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global epinephrine autoinjector market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global epinephrine autoinjector market?
  • What is the impact of each driver, restraint, and opportunity on the global epinephrine autoinjector market?
  • What are the key regional markets?
  • Which countries represent the most attractive epinephrine autoinjector markets?
  • What is the breakup of the market based on the dosage?
  • Which is the most attractive dosage in the epinephrine autoinjector market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the epinephrine autoinjector market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the epinephrine autoinjector market?
  • What is the competitive structure of the global epinephrine autoinjector market?
  • Who are the key players/companies in the global epinephrine autoinjector market?

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the epinephrine autoinjector market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the global epinephrine autoinjector market.
  • The study maps the leading as well as the fastest growing regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the epinephrine autoinjector industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and  provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Epinephrine Autoinjector Market Report by Dosage (0.15mg Epinephrine Autoinjector, 0.3mg Epinephrine Autoinjector, 0.5mg Epinephrine Autoinjector), Application (Under 6 Years, 6 to 12 Years, Over 12 Years), End User (Hospitals, Clinics, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More